|
|
|
|
|
|
by mlac
1611 days ago
|
|
|
> 10 full blood panel samples a year Also, because we haven’t done this at scale, we don’t know the true baseline for most people who may have something on the blood panel samples but never get tested because they are asymptomatic. So then we have this whole group of people with recommended treatment because of the results, even though they are asymptomatic. And they are treated, which then leads to increased costs and side effects… And now we’ve effectively increased medical costs and decreased quality of life for asymptomatic patients. BUT - if we do it with just a drop of blood, we might be able to start a startup and raise some funding… We could call it Thermos or something… |
|
|